STAT Plus: Vaccine development becomes reality TV. Can it make viewers rethink pharma?
The pharmaceutical industry’s response to the novel coronavirus may not rescue its ailing reputation. But it will, apparently, be televised — and the footage could nudge the public’s perception of how the drug business works.
That, at least, is the thinking behind a 30-minute weekly show from the multinational drug company Johnson & Johnson being launched Tuesday. The eight-episode series, which will be broadcast live online, will focus on the company’s efforts to find a vaccine for the virus that causes Covid-19. J&J hired journalist Lisa Ling, of CNN’s “This Is Life,” to host the program.
Continue to STAT Plus to read the full story…
